Home > Boards > US Listed > Biotechs > Verastem (VSTM)

Buying May 17 $2.50 calls here, earnings on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DrHarleyboy Member Profile
Member Level 
Followed By 58
Posts 14,800
Boards Moderated 6
Alias Born 01/08/08
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2019 4:29:18 PM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 7/3/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:12:40 PM
Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data in Peripheral T-Cell Lymphoma at the 2019 International Conference on... Business Wire - 6/21/2019 7:00:00 AM
Verastem Oncology Announces Leadership Changes Business Wire - 6/20/2019 7:00:00 AM
Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data at the European Hematology Association 2019 Annual Meeting Business Wire - 6/17/2019 7:00:00 AM
Verastem Oncology to Present at the Jefferies 2019 Global Healthcare Conference Business Wire - 5/30/2019 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/20/2019 5:23:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2019 4:22:02 PM
Verastem Oncology to Present at the 20th Annual B. Riley FBR Institutional Investor Conference Business Wire - 5/16/2019 7:00:00 AM
Verastem Oncology to Present New COPIKTRA™ (Duvelisib) Dose Modification Data from Patients Treated in the Phase 3 DUO Study Business Wire - 5/15/2019 5:16:00 PM
Verastem Oncology Reports First Quarter 2019 Financial Results Business Wire - 5/9/2019 4:05:00 PM
Verastem Oncology to Announce First Quarter 2019 Financial Results and Corporate Update on May 9, 2019 Business Wire - 5/2/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:22:15 PM
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility Business Wire - 4/23/2019 4:05:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/8/2019 4:13:23 PM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 4/4/2019 4:05:00 PM
Verastem Oncology to Present at the H.C. Wainwright Global Life Sciences Conference Business Wire - 4/2/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/19/2019 4:14:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/18/2019 6:10:17 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/12/2019 4:28:34 PM
Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments Business Wire - 3/12/2019 4:08:00 PM
Verastem Oncology to Present at Upcoming Investor Conferences Business Wire - 3/12/2019 7:00:00 AM
Verastem Oncology Presents Further COPIKTRA™ (Duvelisib) Data at the 23rd Annual International Congress on Hematologic Mali... Business Wire - 3/7/2019 5:01:00 PM
Verastem Oncology Presents Phase 3 DUO™ Data Evaluating COPIKTRA™ (Duvelisib) in Patients with CLL/SLL Who Have Progresse... Business Wire - 3/4/2019 7:00:00 AM
DrHarleyboy Member Level  Monday, 04/29/19 10:14:27 AM
Re: None
Post # of 411 
Buying May 17 $2.50 calls here, earnings on tap this week, and stock well below value area here, could get a nice pop.

“The truth is incontrovertible, malice may attack it, ignorance may deride it, but in the end; there it is.”


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist